Compared to standard insulin treatment, noninsulin antidiabetic agents did not present an increased risk for fetal losses or major malformations when used in the first trimester of pregnancy.
Original Article: Risk for Fetal Loss Early in Pregnancy Not Greater With Noninsulin vs Insulin Therapy